Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02635035
Recruitment Status : Completed
First Posted : December 18, 2015
Last Update Posted : September 24, 2019
Information provided by (Responsible Party):
NYU Langone Health

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 9, 2019
Actual Study Completion Date : January 9, 2019